MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 169 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,000 | +33.3% | 127 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $3,000 | +50.0% | 127 | +12.4% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | +100.0% | 113 | +43.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 79 | -33.6% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 119 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $2,000 | +100.0% | 119 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 119 | +38.4% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | 0.0% | 86 | -23.2% | 0.00% | 0.0% |
| Q2 2018 | $2,000 | +100.0% | 112 | +53.4% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | -50.0% | 73 | -47.9% | 0.00% | 0.0% |
| Q3 2016 | $2,000 | +100.0% | 140 | +91.8% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $28,350,000 | 2.16% |
| SENZAR ASSET MANAGEMENT, LLC | 454,600 | $5,155,000 | 1.51% |
| Palo Alto Investors LP | 1,455,176 | $16,502,000 | 1.23% |
| SECTORAL ASSET MANAGEMENT INC | 2,134,440 | $24,205,000 | 1.02% |
| AlphaMark Advisors, LLC | 130,699 | $1,482,000 | 0.94% |
| Cheyne Capital Management (UK) LLP | 172,353 | $1,955,000 | 0.70% |
| Regal Investment Advisors LLC | 183,972 | $2,086,000 | 0.63% |
| Tekla Capital Management LLC | 1,067,575 | $12,106,000 | 0.57% |
| March Altus Capital Management LP | 103,729 | $1,176,000 | 0.47% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 19,500 | $221,000 | 0.33% |